RSV Vaccine and mAb Snapshot

This slide provides a snapshot of the respiratory syncytial virus (RSV) vaccine and monoclonal antibody (mAb) technology landscape, in the effort to track the development of RSV vaccine and mAb candidates and provide a summary of the various vaccine approaches being worked on worldwide.

Publication date: April 2019

Available materials

    1. RSV Vaccine and mAb Snapshot (PDF) 473.8 KB PDF

      Hard copies are not available.

    2. RSV Vaccine and mAb Snapshot (PowerPoint) 737.2 KB PPTX